25 XP   0   0   10

Tianjin TEDA Biomedical Engineering Co Ltd
Buy, Hold or Sell?

Let's analyse Tianjin TEDA Biomedical Engineering Co Ltd together

PenkeI guess you are interested in Tianjin TEDA Biomedical Engineering Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tianjin TEDA Biomedical Engineering Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tianjin TEDA Biomedical Engineering Co Ltd

I send you an email if I find something interesting about Tianjin TEDA Biomedical Engineering Co Ltd.

Quick analysis of Tianjin TEDA Biomedical Engineering Co Ltd (30 sec.)










What can you expect buying and holding a share of Tianjin TEDA Biomedical Engineering Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.04
Expected worth in 1 year
HK$-0.02
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.06
Return On Investment
-85.4%

For what price can you sell your share?

Current Price per Share
HK$0.08
Expected price per share
HK$0.066 - HK$0.092
How sure are you?
50%

1. Valuation of Tianjin TEDA Biomedical Engineering Co Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.08

Intrinsic Value Per Share

HK$-0.20 - HK$0.05

Total Value Per Share

HK$-0.16 - HK$0.09

2. Growth of Tianjin TEDA Biomedical Engineering Co Ltd (5 min.)




Is Tianjin TEDA Biomedical Engineering Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$10m$13.8m-$3.8m-38.7%

How much money is Tianjin TEDA Biomedical Engineering Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.8m-$5.8m$1.9m50.3%
Net Profit Margin-6.3%-8.9%--

How much money comes from the company's main activities?

3. Financial Health of Tianjin TEDA Biomedical Engineering Co Ltd (5 min.)




4. Comparing to competitors in the Agricultural Inputs industry (5 min.)




  Industry Rankings (Agricultural Inputs)  


Richest
#134 / 157

Most Revenue
#108 / 157

Most Profit
#133 / 157

Most Efficient
#125 / 157

What can you expect buying and holding a share of Tianjin TEDA Biomedical Engineering Co Ltd? (5 min.)

Welcome investor! Tianjin TEDA Biomedical Engineering Co Ltd's management wants to use your money to grow the business. In return you get a share of Tianjin TEDA Biomedical Engineering Co Ltd.

What can you expect buying and holding a share of Tianjin TEDA Biomedical Engineering Co Ltd?

First you should know what it really means to hold a share of Tianjin TEDA Biomedical Engineering Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tianjin TEDA Biomedical Engineering Co Ltd is HK$0.075. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tianjin TEDA Biomedical Engineering Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tianjin TEDA Biomedical Engineering Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.04. Based on the TTM, the Book Value Change Per Share is HK$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tianjin TEDA Biomedical Engineering Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.00-2.7%0.00-2.7%0.00-4.1%-0.01-7.4%0.00-3.0%
Usd Book Value Change Per Share0.00-2.7%0.00-2.7%0.00-5.3%-0.01-11.1%0.00-1.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-2.7%0.00-2.7%0.00-5.3%-0.01-11.1%0.00-1.9%
Usd Price Per Share0.03-0.03-0.02-0.02-0.06-
Price to Earnings Ratio-12.49--12.49--7.06--5.71-30.27-
Price-to-Total Gains Ratio-12.49--12.49--5.49--5.07--5.87-
Price to Book Ratio4.83-4.83-2.96-2.34-3.00-
Price-to-Total Gains Ratio-12.49--12.49--5.49--5.07--5.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0095775
Number of shares104411
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (104411 shares)-213.54-866.04
Gains per Year (104411 shares)-854.14-3,464.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-854-8640-3464-3474
20-1708-17180-6928-6938
30-2562-25720-10392-10402
40-3417-34260-13857-13866
50-4271-42800-17321-17330
60-5125-51340-20785-20794
70-5979-59880-24249-24258
80-6833-68420-27713-27722
90-7687-76960-31177-31186
100-8541-85500-34641-34650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.08.03.047.6%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.011.00.047.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.021.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.011.00.047.6%

Fundamentals of Tianjin TEDA Biomedical Engineering Co Ltd

About Tianjin TEDA Biomedical Engineering Co Ltd

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in three segments: Biological Compound Fertilizers Products; Elderly Care and Health Care Services; and Health Care Products (Wine) and Related Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; trading of wine and specializing in system platform development; and provision of soil environmental quality standards research services, as well as information transmission, software, and information technology service industry. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-18 20:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tianjin TEDA Biomedical Engineering Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tianjin TEDA Biomedical Engineering Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • A Net Profit Margin of -6.3% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is -6.3%. The company is making a loss. -1
  • The TTM is -6.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-6.3%0.0%
TTM-6.3%YOY-8.9%+2.6%
TTM-6.3%5Y-20.4%+14.2%
5Y-20.4%10Y-9.2%-11.2%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%4.9%-11.2%
TTM-6.3%5.3%-11.6%
YOY-8.9%7.9%-16.8%
5Y-20.4%5.4%-25.8%
10Y-9.2%3.9%-13.1%
1.1.2. Return on Assets

Shows how efficient Tianjin TEDA Biomedical Engineering Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • -8.3% Return on Assets means that Tianjin TEDA Biomedical Engineering Co Ltd generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is -8.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-8.3%0.0%
TTM-8.3%YOY-12.2%+3.8%
TTM-8.3%5Y-19.1%+10.8%
5Y-19.1%10Y-8.1%-11.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.3%3.1%-11.4%
TTM-8.3%3.0%-11.3%
YOY-12.2%3.5%-15.7%
5Y-19.1%1.8%-20.9%
10Y-8.1%1.5%-9.6%
1.1.3. Return on Equity

Shows how efficient Tianjin TEDA Biomedical Engineering Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • -38.7% Return on Equity means Tianjin TEDA Biomedical Engineering Co Ltd generated $-0.39 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is -38.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -38.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.7%TTM-38.7%0.0%
TTM-38.7%YOY-41.9%+3.3%
TTM-38.7%5Y-44.7%+6.0%
5Y-44.7%10Y-19.7%-25.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.7%5.7%-44.4%
TTM-38.7%5.5%-44.2%
YOY-41.9%7.6%-49.5%
5Y-44.7%4.8%-49.5%
10Y-19.7%3.9%-23.6%

1.2. Operating Efficiency of Tianjin TEDA Biomedical Engineering Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tianjin TEDA Biomedical Engineering Co Ltd is operating .

  • Measures how much profit Tianjin TEDA Biomedical Engineering Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.9%+3.9%
TTM-5Y-5.8%+5.8%
5Y-5.8%10Y-0.7%-5.1%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.2%-9.2%
TTM-7.4%-7.4%
YOY-3.9%10.7%-14.6%
5Y-5.8%8.2%-14.0%
10Y-0.7%6.5%-7.2%
1.2.2. Operating Ratio

Measures how efficient Tianjin TEDA Biomedical Engineering Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • An Operation Ratio of 2.01 means that the operating costs are $2.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 2.013. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.013. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.013TTM2.0130.000
TTM2.013YOY1.918+0.094
TTM2.0135Y1.614+0.399
5Y1.61410Y1.285+0.329
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0131.564+0.449
TTM2.0131.589+0.424
YOY1.9181.446+0.472
5Y1.6141.564+0.050
10Y1.2851.314-0.029

1.3. Liquidity of Tianjin TEDA Biomedical Engineering Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tianjin TEDA Biomedical Engineering Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A Current Ratio of 0.88 means the company has $0.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 0.885. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.885. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.885TTM0.8850.000
TTM0.885YOY1.087-0.202
TTM0.8855Y1.361-0.476
5Y1.36110Y1.907-0.546
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8851.609-0.724
TTM0.8851.628-0.743
YOY1.0871.688-0.601
5Y1.3611.763-0.402
10Y1.9071.637+0.270
1.3.2. Quick Ratio

Measures if Tianjin TEDA Biomedical Engineering Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • A Quick Ratio of 0.20 means the company can pay off $0.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.2020.000
TTM0.202YOY0.340-0.137
TTM0.2025Y0.563-0.361
5Y0.56310Y0.869-0.306
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2020.535-0.333
TTM0.2020.621-0.419
YOY0.3400.684-0.344
5Y0.5630.757-0.194
10Y0.8690.803+0.066

1.4. Solvency of Tianjin TEDA Biomedical Engineering Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tianjin TEDA Biomedical Engineering Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to Agricultural Inputs industry mean.
  • A Debt to Asset Ratio of 0.78 means that Tianjin TEDA Biomedical Engineering Co Ltd assets are financed with 78.4% credit (debt) and the remaining percentage (100% - 78.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 0.784. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.784. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.784TTM0.7840.000
TTM0.784YOY0.710+0.074
TTM0.7845Y0.576+0.208
5Y0.57610Y0.445+0.131
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7840.448+0.336
TTM0.7840.450+0.334
YOY0.7100.456+0.254
5Y0.5760.479+0.097
10Y0.4450.496-0.051
1.4.2. Debt to Equity Ratio

Measures if Tianjin TEDA Biomedical Engineering Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • A Debt to Equity ratio of 364.0% means that company has $3.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The MRQ is 3.640. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.640. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.640TTM3.6400.000
TTM3.640YOY2.449+1.191
TTM3.6405Y1.829+1.811
5Y1.82910Y1.204+0.625
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6400.799+2.841
TTM3.6400.810+2.830
YOY2.4490.872+1.577
5Y1.8290.967+0.862
10Y1.2041.065+0.139

2. Market Valuation of Tianjin TEDA Biomedical Engineering Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tianjin TEDA Biomedical Engineering Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tianjin TEDA Biomedical Engineering Co Ltd to the Agricultural Inputs industry mean.
  • A PE ratio of -12.49 means the investor is paying $-12.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The EOD is -4.683. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.488. Based on the earnings, the company is expensive. -2
  • The TTM is -12.488. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.683MRQ-12.488+7.805
MRQ-12.488TTM-12.4880.000
TTM-12.488YOY-7.061-5.428
TTM-12.4885Y-5.714-6.775
5Y-5.71410Y30.268-35.981
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-4.6838.054-12.737
MRQ-12.4889.200-21.688
TTM-12.48810.599-23.087
YOY-7.06111.668-18.729
5Y-5.71415.306-21.020
10Y30.26820.446+9.822
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The EOD is -6.088. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.235. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.235. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.088MRQ-16.235+10.147
MRQ-16.235TTM-16.2350.000
TTM-16.235YOY-7.388-8.847
TTM-16.2355Y-14.831-1.404
5Y-14.83110Y-63.127+48.296
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-6.0880.371-6.459
MRQ-16.2350.372-16.607
TTM-16.2350.005-16.240
YOY-7.3880.786-8.174
5Y-14.8310.582-15.413
10Y-63.1270.142-63.269
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tianjin TEDA Biomedical Engineering Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A PB ratio of 4.83 means the investor is paying $4.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tianjin TEDA Biomedical Engineering Co Ltd:

  • The EOD is 1.811. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.830. Based on the equity, the company is fair priced.
  • The TTM is 4.830. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.811MRQ4.830-3.019
MRQ4.830TTM4.8300.000
TTM4.830YOY2.960+1.869
TTM4.8305Y2.340+2.489
5Y2.34010Y2.997-0.656
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD1.8111.403+0.408
MRQ4.8301.559+3.271
TTM4.8301.666+3.164
YOY2.9602.402+0.558
5Y2.3401.954+0.386
10Y2.9972.656+0.341
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tianjin TEDA Biomedical Engineering Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.0160%-0.031+93%-0.065+306%-0.011-30%
Book Value Per Share--0.0410.0410%0.057-28%0.094-56%0.167-75%
Current Ratio--0.8850.8850%1.087-19%1.361-35%1.907-54%
Debt To Asset Ratio--0.7840.7840%0.710+10%0.576+36%0.445+76%
Debt To Equity Ratio--3.6403.6400%2.449+49%1.829+99%1.204+202%
Dividend Per Share----0%-0%-0%-0%
Eps---0.016-0.0160%-0.024+50%-0.043+171%-0.017+9%
Free Cash Flow Per Share---0.012-0.0120%-0.023+87%-0.009-27%-0.012-3%
Free Cash Flow To Equity Per Share---0.009-0.0090%-0.007-21%-0.005-46%0.002-654%
Gross Profit Margin--1.0001.0000%1.0000%1.138-12%0.302+232%
Intrinsic Value_10Y_max--0.045--------
Intrinsic Value_10Y_min---0.205--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.014--------
Intrinsic Value_3Y_max---0.008--------
Intrinsic Value_3Y_min---0.049--------
Intrinsic Value_5Y_max---0.002--------
Intrinsic Value_5Y_min---0.089--------
Market Cap89774995.200-322%379000000.000379000000.0000%322150000.000+18%334278000.000+13%764171397.264-50%
Net Profit Margin---0.063-0.0630%-0.089+42%-0.204+227%-0.092+48%
Operating Margin----0%-0.0390%-0.0580%-0.0070%
Operating Ratio--2.0132.0130%1.918+5%1.614+25%1.285+57%
Pb Ratio1.811-167%4.8304.8300%2.960+63%2.340+106%2.997+61%
Pe Ratio-4.683+63%-12.488-12.4880%-7.061-43%-5.714-54%30.268-141%
Price Per Share0.075-167%0.2000.2000%0.170+18%0.176+13%0.482-59%
Price To Free Cash Flow Ratio-6.088+63%-16.235-16.2350%-7.388-54%-14.831-9%-63.127+289%
Price To Total Gains Ratio-4.683+63%-12.488-12.4880%-5.488-56%-5.073-59%-5.871-53%
Quick Ratio--0.2020.2020%0.340-40%0.563-64%0.869-77%
Return On Assets---0.083-0.0830%-0.122+46%-0.191+130%-0.081-2%
Return On Equity---0.387-0.3870%-0.419+8%-0.447+16%-0.197-49%
Total Gains Per Share---0.016-0.0160%-0.031+93%-0.065+306%-0.011-30%
Usd Book Value--10021128.50910021128.5090%13896686.051-28%22773252.728-56%35339374.203-72%
Usd Book Value Change Per Share---0.002-0.0020%-0.004+93%-0.008+306%-0.001-30%
Usd Book Value Per Share--0.0050.0050%0.007-28%0.012-56%0.021-75%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%-0.003+50%-0.006+171%-0.002+9%
Usd Free Cash Flow---2981084.604-2981084.6040%-5568102.267+87%-2168087.720-27%-2591619.315-13%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.003+87%-0.001-27%-0.002-3%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.001-21%-0.001-46%0.000-654%
Usd Market Cap11464266.887-322%48398300.00048398300.0000%41138555.000+18%42687300.600+13%97584687.431-50%
Usd Price Per Share0.010-167%0.0260.0260%0.022+18%0.023+13%0.062-59%
Usd Profit---3875558.921-3875558.9210%-5826566.903+50%-10497908.795+171%-4463748.121+15%
Usd Revenue--62006023.59662006023.5960%65688908.178-6%55323451.912+12%60782014.990+2%
Usd Total Gains Per Share---0.002-0.0020%-0.004+93%-0.008+306%-0.001-30%
 EOD+3 -5MRQTTM+0 -0YOY+18 -145Y+16 -1710Y+8 -25

3.2. Fundamental Score

Let's check the fundamental score of Tianjin TEDA Biomedical Engineering Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.683
Price to Book Ratio (EOD)Between0-11.811
Net Profit Margin (MRQ)Greater than0-0.063
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.202
Current Ratio (MRQ)Greater than10.885
Debt to Asset Ratio (MRQ)Less than10.784
Debt to Equity Ratio (MRQ)Less than13.640
Return on Equity (MRQ)Greater than0.15-0.387
Return on Assets (MRQ)Greater than0.05-0.083
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Tianjin TEDA Biomedical Engineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.892
Ma 20Greater thanMa 500.087
Ma 50Greater thanMa 1000.087
Ma 100Greater thanMa 2000.089
OpenGreater thanClose0.075
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Working Capital  147,489-41,959105,531-34,41971,112-53,05218,060-45,243-27,184
Minority Interest  20,151-4,52315,628-2,55413,074-10,3432,731-4,308-1,577



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets337,196
Total Liabilities264,522
Total Stockholder Equity72,675
 As reported
Total Liabilities 264,522
Total Stockholder Equity+ 72,675
Total Assets = 337,196

Assets

Total Assets337,196
Total Current Assets193,075
Long-term Assets144,122
Total Current Assets
Cash And Cash Equivalents 6,856
Short-term Investments 2,693
Net Receivables 31,867
Inventory 74,004
Total Current Assets  (as reported)193,075
Total Current Assets  (calculated)115,420
+/- 77,655
Long-term Assets
Property Plant Equipment 118,493
Goodwill 5,528
Intangible Assets 6,546
Long-term Assets  (as reported)144,122
Long-term Assets  (calculated)130,566
+/- 13,556

Liabilities & Shareholders' Equity

Total Current Liabilities218,249
Long-term Liabilities35,234
Total Stockholder Equity72,675
Total Current Liabilities
Short-term Debt 12,800
Short Long Term Debt 56,800
Accounts payable 20,723
Other Current Liabilities 13,706
Total Current Liabilities  (as reported)218,249
Total Current Liabilities  (calculated)104,029
+/- 114,220
Long-term Liabilities
Long term Debt Total 35,234
Long-term Liabilities  (as reported)35,234
Long-term Liabilities  (calculated)35,234
+/- 0
Total Stockholder Equity
Common Stock189,450
Retained Earnings -392,093
Capital Surplus 275,317
Total Stockholder Equity (as reported)72,675
Total Stockholder Equity (calculated)72,675
+/-0
Other
Capital Stock189,450
Cash and Short Term Investments 9,549
Common Stock Shares Outstanding 1,895,000
Liabilities and Stockholders Equity 337,196
Net Debt 49,944
Net Invested Capital 129,475
Net Working Capital -25,175
Property Plant and Equipment Gross 225,989



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
117,051
107,999
123,656
208,266
278,839
325,601
309,551
309,136
309,073
324,299
421,976
412,864
432,622
458,505
459,628
707,878
448,980
361,913
392,919
347,595
337,196
337,196347,595392,919361,913448,980707,878459,628458,505432,622412,864421,976324,299309,073309,136309,551325,601278,839208,266123,656107,999117,051
   > Total Current Assets 
0
0
0
130,878
141,410
180,434
187,360
189,488
190,050
220,903
319,925
324,463
324,694
358,882
370,869
307,618
293,901
254,138
260,173
208,749
193,075
193,075208,749260,173254,138293,901307,618370,869358,882324,694324,463319,925220,903190,050189,488187,360180,434141,410130,878000
       Cash And Cash Equivalents 
40,528
12,913
5,995
16,767
11,278
17,582
17,887
42,557
46,992
32,337
23,346
43,109
48,384
105,637
85,743
37,592
43,129
24,247
13,532
26,439
6,856
6,85626,43913,53224,24743,12937,59285,743105,63748,38443,10923,34632,33746,99242,55717,88717,58211,27816,7675,99512,91340,528
       Short-term Investments 
24,936
25,044
25,044
0
8,550
27,800
18,140
38,755
4,953
43,601
16,712
1,000
0
0
0
0
9,026
634
22,000
3,340
2,693
2,6933,34022,0006349,02600001,00016,71243,6014,95338,75518,14027,8008,550025,04425,04424,936
       Net Receivables 
20,002
22,302
42,447
67,238
61,008
80,467
72,358
59,010
53,797
68,863
129,139
129,433
116,682
83,305
112,376
110,244
91,752
84,352
58,965
32,082
31,867
31,86732,08258,96584,35291,752110,244112,37683,305116,682129,433129,13968,86353,79759,01072,35880,46761,00867,23842,44722,30220,002
       Other Current Assets 
0
0
0
16,378
22,729
3,306
0
320
320
304
52,520
41,783
21,252
64,935
104,285
67,082
64,376
56,605
74,033
63,214
0
063,21474,03356,60564,37667,082104,28564,93521,25241,78352,52030432032003,30622,72916,378000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,758
400,259
155,078
107,775
132,746
138,847
144,122
144,122138,847132,746107,775155,078400,25988,75800000000000000
       Property Plant Equipment 
14,390
15,574
17,394
41,487
97,855
106,005
110,241
108,010
101,111
80,078
81,864
76,648
96,371
70,715
63,955
69,898
71,338
69,321
126,342
124,967
118,493
118,493124,967126,34269,32171,33869,89863,95570,71596,37176,64881,86480,078101,111108,010110,241106,00597,85541,48717,39415,57414,390
       Goodwill 
4,969
4,665
3,367
3,367
3,134
3,134
3,134
3,134
3,134
3,134
3,134
3,134
3,134
0
0
12,150
12,150
8,400
420
0
5,528
5,52804208,40012,15012,150003,1343,1343,1343,1343,1343,1343,1343,1343,1343,3673,3674,6654,969
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
20,675
16,760
13,452
17,660
0
0
0
0
000017,66013,45216,76020,6750000000000000
       Intangible Assets 
9,002
7,818
7,107
1,408
3,134
3,134
3,134
3,134
3,134
3,134
3,134
3,134
3,134
0
0
262,145
18,045
3,897
2,036
37
6,546
6,546372,0363,89718,045262,145003,1343,1343,1343,1343,1343,1343,1343,1343,1341,4087,1077,8189,002
       Other Assets 
0
8,956
7,627
5,662
16,141
7,928
5,817
5,504
11,778
17,184
17,052
8,619
8,423
8,233
8,044
42,614
35,885
12,515
0
0
0
00012,51535,88542,6148,0448,2338,4238,61917,05217,18411,7785,5045,8177,92816,1415,6627,6278,9560
> Total Liabilities 
41,210
55,948
90,352
110,393
208,097
266,607
224,996
150,432
142,376
145,888
219,346
188,093
188,924
114,072
110,244
133,078
157,312
156,406
237,775
246,815
264,522
264,522246,815237,775156,406157,312133,078110,244114,072188,924188,093219,346145,888142,376150,432224,996266,607208,097110,39390,35255,94841,210
   > Total Current Liabilities 
40,510
54,479
89,061
109,102
206,806
266,607
216,996
150,432
137,376
145,888
219,346
188,093
188,924
114,072
110,244
133,078
157,312
156,406
194,316
192,024
218,249
218,249192,024194,316156,406157,312133,078110,244114,072188,924188,093219,346145,888137,376150,432216,996266,607206,806109,10289,06154,47940,510
       Short-term Debt 
0
0
0
0
0
0
0
0
4,953
0
0
102,300
87,300
45,000
40,000
40,000
9,026
634
9,400
41,400
12,800
12,80041,4009,4006349,02640,00040,00045,00087,300102,300004,95300000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
102,300
87,300
45,000
40,000
40,000
49,500
31,200
9,400
41,400
56,800
56,80041,4009,40031,20049,50040,00040,00045,00087,300102,30000000000000
       Accounts payable 
1,630
2,201
13,804
20,908
39,270
105,902
40,097
46,441
35,805
13,087
67,496
55,407
39,927
24,748
15,998
22,124
40,176
19,284
43,768
29,533
20,723
20,72329,53343,76819,28440,17622,12415,99824,74839,92755,40767,49613,08735,80546,44140,097105,90239,27020,90813,8042,2011,630
       Other Current Liabilities 
11,280
14,265
16,110
36,347
62,789
64,005
88,900
55,491
24,071
39,301
68,550
30,386
61,697
38,919
22,860
35,345
60,258
93,990
133,108
117,360
13,706
13,706117,360133,10893,99060,25835,34522,86038,91961,69730,38668,55039,30124,07155,49188,90064,00562,78936,34716,11014,26511,280
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,459
45,212
35,234
35,23445,21243,459000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,459
45,212
35,234
35,23445,21243,459000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-4,953
0
0
-102,300
-87,300
-45,000
-40,000
-40,000
-9,026
5,585
29,450
1,543
26,412
26,4121,54329,4505,585-9,026-40,000-40,000-45,000-87,300-102,30000-4,95300000000
> Total Stockholder Equity
70,932
46,089
30,543
65,374
68,408
57,031
81,823
134,919
141,061
156,039
180,056
201,429
198,021
319,937
325,908
422,954
273,006
191,034
143,036
100,781
72,675
72,675100,781143,036191,034273,006422,954325,908319,937198,021201,429180,056156,039141,061134,91981,82357,03168,40865,37430,54346,08970,932
   Common Stock
40,000
40,000
40,000
61,000
61,000
61,000
95,000
142,000
142,000
142,000
142,000
142,000
142,000
159,500
159,500
169,500
189,450
189,450
189,450
189,450
189,450
189,450189,450189,450189,450189,450169,500159,500159,500142,000142,000142,000142,000142,000142,00095,00061,00061,00061,00040,00040,00040,000
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 00-97,147-93,867-78,532-71,709-66,855-59,143-59,630-54,861-47,602-40,209-49,726-43,255-41,546-35,614-29,584-26,013000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
154,668
154,668
255,466
275,317
275,317
275,317
275,317
275,317
275,317275,317275,317275,317275,317255,466154,668154,6680000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
2,541
-19,491
-19,491
-19,491
-19,491
-19,491
-16,841
-16,841
-16,841
0
0-16,841-16,841-16,841-19,491-19,491-19,491-19,491-19,4912,54100000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue449,935
Cost of Revenue-433,228
Gross Profit16,70716,707
 
Operating Income (+$)
Gross Profit16,707
Operating Expense-468,391
Operating Income-18,456-451,684
 
Operating Expense (+$)
Research Development200
Selling General Administrative35,078
Selling And Marketing Expenses-
Operating Expense468,39135,278
 
Net Interest Income (+$)
Interest Income-
Interest Expense-4,839
Other Finance Cost-763
Net Interest Income-4,077
 
Pretax Income (+$)
Operating Income-18,456
Net Interest Income-4,077
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-24,646-18,456
EBIT - interestExpense = -4,839
-23,773
-18,934
Interest Expense4,839
Earnings Before Interest and Taxes (EBIT)--19,807
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-24,646
Tax Provision--37
Net Income From Continuing Ops-24,609-24,609
Net Income-23,773
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-4,077
 

Technical Analysis of Tianjin TEDA Biomedical Engineering Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tianjin TEDA Biomedical Engineering Co Ltd. The general trend of Tianjin TEDA Biomedical Engineering Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tianjin TEDA Biomedical Engineering Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tianjin TEDA Biomedical Engineering Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.092 < 0.092 < 0.092.

The bearish price targets are: 0.074 > 0.066 > 0.066.

Tweet this
Tianjin TEDA Biomedical Engineering Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tianjin TEDA Biomedical Engineering Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tianjin TEDA Biomedical Engineering Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tianjin TEDA Biomedical Engineering Co Ltd. The current macd is -0.0029865.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tianjin TEDA Biomedical Engineering Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tianjin TEDA Biomedical Engineering Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tianjin TEDA Biomedical Engineering Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tianjin TEDA Biomedical Engineering Co Ltd. The current adx is 43.05.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tianjin TEDA Biomedical Engineering Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Tianjin TEDA Biomedical Engineering Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tianjin TEDA Biomedical Engineering Co Ltd. The current sar is 0.08942499.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tianjin TEDA Biomedical Engineering Co Ltd. The current rsi is 30.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Tianjin TEDA Biomedical Engineering Co Ltd Daily Relative Strength Index (RSI) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tianjin TEDA Biomedical Engineering Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tianjin TEDA Biomedical Engineering Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Stochastic Oscillator ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tianjin TEDA Biomedical Engineering Co Ltd. The current cci is -125.2457175.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Commodity Channel Index (CCI) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tianjin TEDA Biomedical Engineering Co Ltd. The current cmo is -42.11746603.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tianjin TEDA Biomedical Engineering Co Ltd. The current willr is -70.83333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Tianjin TEDA Biomedical Engineering Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tianjin TEDA Biomedical Engineering Co Ltd Daily Williams %R ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tianjin TEDA Biomedical Engineering Co Ltd.

Tianjin TEDA Biomedical Engineering Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tianjin TEDA Biomedical Engineering Co Ltd. The current atr is 0.00300413.

Tianjin TEDA Biomedical Engineering Co Ltd Daily Average True Range (ATR) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tianjin TEDA Biomedical Engineering Co Ltd. The current obv is 7,930,000.

Tianjin TEDA Biomedical Engineering Co Ltd Daily On-Balance Volume (OBV) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tianjin TEDA Biomedical Engineering Co Ltd. The current mfi is 15.38.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Tianjin TEDA Biomedical Engineering Co Ltd Daily Money Flow Index (MFI) ChartTianjin TEDA Biomedical Engineering Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tianjin TEDA Biomedical Engineering Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Tianjin TEDA Biomedical Engineering Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tianjin TEDA Biomedical Engineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.892
Ma 20Greater thanMa 500.087
Ma 50Greater thanMa 1000.087
Ma 100Greater thanMa 2000.089
OpenGreater thanClose0.075
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tianjin TEDA Biomedical Engineering Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tianjin TEDA Biomedical Engineering Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tianjin TEDA Biomedical Engineering Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tianjin TEDA Biomedical Engineering Co Ltd

I send you an email if I find something interesting about Tianjin TEDA Biomedical Engineering Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tianjin TEDA Biomedical Engineering Co Ltd.

Receive notifications about Tianjin TEDA Biomedical Engineering Co Ltd in your mailbox!